OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interactions between tumor-derived proteins and Toll-like receptors
Gun-Young Jang, Ji‐Won Lee, Young Seob Kim, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 12, pp. 1926-1935
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1599

Exosome-Based Vaccines: History, Current State, and Clinical Trials
Patrick Santos, Fausto Almeida
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 156

The immune microenvironment in gastric adenocarcinoma
Yana Zavros, Juanita L. Merchant
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 7, pp. 451-467
Open Access | Times Cited: 91

Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 61

DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways
Yi Huang, Wei Jiang, Rongbin Zhou
Nature reviews. Immunology (2024) Vol. 24, Iss. 10, pp. 703-719
Closed Access | Times Cited: 23

Hyaluronan Receptors as Mediators and Modulators of the Tumor Microenvironment
Ana M. Carvalho, Rui L. Reis, Iva Pashkuleva
Advanced Healthcare Materials (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 44

Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy
Bradley N. Mills, Haoming Qiu, Michael G. Drage, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 1, pp. 150-162
Open Access | Times Cited: 51

S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis
Meike von Wulffen, Veronika Luehrmann, Stefanie Robeck, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 113006-113006
Open Access | Times Cited: 20

Strategies for Heating Up Cold Tumors to Boost Immunotherapies
Daniel J. Zabransky, Mark Yarchoan, Elizabeth M. Jaffee
Annual Review of Cancer Biology (2023) Vol. 7, Iss. 1, pp. 149-170
Closed Access | Times Cited: 16

Immunometabolic reprogramming, another cancer hallmark
Vijay Kumar, John H. Stewart
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16

High efficiency preparation of monodisperse plasma membrane derived extracellular vesicles for therapeutic applications
Claudio Luca Alter, Pascal Detampel, Roman B. Schefer, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 13

Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis
Tianyu Li, Tolulope Akinade, Jie Zhou, et al.
Advanced Science (2022) Vol. 9, Iss. 33
Open Access | Times Cited: 22

Inducing immunogenic cell death in immuno-oncological therapies
Dongdong Ti, Xin Yan, Jianshu Wei, et al.
Chinese Journal of Cancer Research (2022) Vol. 34, Iss. 1, pp. 1-10
Open Access | Times Cited: 20

Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
Run Zheng, Jian Ma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2285-2285
Open Access | Times Cited: 19

Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models
Euni Cho, Seok‐Jun Mun, Hyo Keun Kim, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 3, pp. 581-593
Closed Access | Times Cited: 11

Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?
Qingyang Liu, Peihua Wu, Jun Lei, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135541-135541
Closed Access | Times Cited: 4

Dengue virus infection: how platelet-leukocyte crosstalk shapes thrombotic events and inflammation
Arash Amin, Farahnaz Nikdoust, Sepehr Khorram, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Autologous Nanovaccine Induces Immunogenic Domino Effect to Prevent Postoperative Recurrence of Orthotopic Glioblastoma
Jinghong Yang, Ke Zhang, Guangliang Zhang, et al.
Advanced Functional Materials (2025)
Closed Access

Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models
Alessandro Sammarco, Giorgia Guerra, Katharina M. Eyme, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access

Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment
Pankaj Ahluwalia, Meenakshi Ahluwalia, Ashis K. Mondal, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4037-4037
Open Access | Times Cited: 26

Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
Wenya Li, G Chen, Hailin Peng, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1161-1161
Open Access | Times Cited: 3

Mechanistic rationales for combining immunotherapy with radiotherapy
Alexander Chi, Nam P. Nguyen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top